Feedback / Questions
NRG5051 - NRG Therap
https://www.globenewswire.com/news-release/2024/10/31/2972343/0/en/NRG-Therapeutics-Selects-First-Development-Candidate-NRG5051-and-Secures-Grant-from-The-Michael-J-Fox-Foundation-for-Development-of-mPTP-Inhibitors-to-Treat-Neurodegenerative-Disea.html
Oct 31, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next